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ANCA: Fuel for the fire or the spark that ignites the flame?
yet to be shown that they are necessary for the onset ofAnti-neutrophil cytoplasmic autoantibodies (ANCA)
disease.have proved to be good serological markers of active
Alternative possible agents that might initiate vascularpauci-immune crescentic glomerulonephritis (GN) and
injury include bacterial products, viral infections, or anecrotizing vasculitides, especially Wegener’s granulo-
cell-mediated immune reaction. Again, there is no directmatosis and microscopic polyarteritis nodosa [1]. It is
evidence for any of these, although patients with pauci-less clear what role, if any, they play in the pathogenesis.
immune GN often have an infectious prodrome, and TAlthough titers of ANCA, against either myeloperoxi-
cell reactivity to the ANCA antigens, MPO and PR3,dase (MPO) or proteinase 3 (PR3), tend to correlate
has been demonstrated in patients with necrotizing vas-with disease activity, there is presently no direct evidence
culitis.that they are either necessary or sufficient to cause vascu-
litis and GN. This is not to say that they are unimportant. Most of the evidence supporting a biological effect
Indeed, it is hard to imagine that autoantibodies that are and possible pathological role for ANCA is derived from
so closely associated with a relatively limited group of in vitro studies. These have shown that the major target
clinicopathological syndromes could represent a nonspe- antigens, MPO and PR3, which are normally contained
cific epiphenomenon. It is just that none of Koch’s postu- within neutrophil and monocyte granules, are translo-
lates has been fulfilled. That is, the pathogen (ANCA) cated to the outer cell surface when the cells are activated
has not been identified in the lesions, it has yet to be with cytokines like interleukin (IL)-1 or tumor necrosis
shown that removing or neutralizing ANCA cures the factor-a or as they undergo apoptosis [1, 4]. If cytokine-
disease, and giving ANCA to experimental animals has primed leukocytes are then exposed to anti-MPO or anti-
not been found to cause the disease. PR3, the antibodies bind the antigen, cross-link FcgII
It is argued that glomerular and/or vascular immune receptors, and cause the cells to degranulate, undergo a
deposits containing ANCA IgG may have been present respiratory burst and damage co-cultured endothelial
at the onset of disease in pauci-immune GN only to be cells [5, 6]. Furthermore, as shown recently with mono-
shed into the circulation or phagocytosed by the time a cytes [7] and with neutrophils by Cockwell and associates
biopsy is taken. For example, a model was developed in in this issue of Kidney International [8], ANCA also
which rats were immunized with MPO and then, when stimulate the release of the potent neutrophil chemoat-
circulating anti-MPO antibodies were present, MPO and tractant, IL-8.
hydrogen peroxide were perfused into the renal artery Interleukin-8 is one of an expanding family of small
to form MPO-anti-MPO complexes [2]. This led to the peptides, called chemokines, that are powerful leukocyte
development of crescentic GN even though glomerular- chemotaxins and activators. The chemokines are subdi-
bound immune complexes subsequently disappeared. vided into four subfamilies—CC, CXC, CX3C and C—
Unfortunately, this model still begs the question because based on the number of conserved cysteines and the
the antigen was purposefully planted in the glomerulus number of amino acids separating the first two cysteines
to serve as a target, which is clearly different than in [9]. IL-8 belongs to the CXC subfamily and has high
spontaneous ANCA-associated GN. Additional evi- specificity for neutrophils [10]. Each of the chemokines
dence against a primary role for ANCA derives from a is remarkably selective for a limited number of leuko-
mouse model that spontaneously develops necrotizing cytes and the presence of particular chemokines within
vasculitis and pauci-immune crescentic GN with circulat- an inflammatory focus dictates what types of leukocytes
ing anti-MPO autoantibodies [3]. Most notably, anti- will be present [9]. This high degree of specificity is
MPO-producing hybridomas from these mice do not conferred by the chemokine receptors (CR) expressed
cause necrotizing vasculitis or crescentic GN when trans- on the leukocyte surface. The receptors for IL-8, CXCR1
ferred to naive recipients. Thus, there is no evidence and CXCR2, are expressed exclusively on neutrophils
that ANCA are sufficient to cause vasculitis and it has [9]. All known chemokine receptors belong to the super-
family of G-protein-coupled receptors with seven trans-
membrane spanning domains. Both CXCR1 and CXCR2Key words: pauci-immune glomerulonephritis, necrotizing vasculiti-
des, renal lesions, myeloperoxidase. have high affinity for IL-8 and activate a pertussis-sensi-
tive signaling cascade that involves phospholipid hydro- 1999 by the International Society of Nephrology
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lysis, intracellular calcium mobilization and protein ki- species, and lipid mediators. Simultaneous release of
nase C activation leading to neutrophil chemotaxis and IL-8 and possibly other chemokines would set up a para-
degranulation [11]. There is also evidence that IL-8 acti- crine loop attracting and activating more leukocytes, up-
vates phosphatidyl inositol 3-kinase and small GTPases, regulating their adhesiveness to endothelium and matrix,
which may contribute to increased neutrophil adhesion and thereby amplifying the inflammation and tissue dam-
[11]. Thus, IL-8 does more than simply attract neutro- age. The proposal by Cockwell et al [8] that the endovas-
phils. It also activates them and promotes their adhesive- cular release of IL-8 might prevent the transmigration
ness. Another feature of IL-8 is its affinity for anionic of neutrophils from glomerular capillaries may be an
glycosaminoglycans such as heparan sulfate. This may overinterpretation of their in vitro data. It does not take
produce an extracellular tissue repository of IL-8 and into account the fact that the Duffy antigen on circulating
provide a long-lasting chemotactic stimulus. red cells, a non-signaling chemokine receptor, serves as
Although several cell types, including kidney epithelial a sink or sponge that soaks up circulating chemokines
and mesangial cells, can be induced to release IL-8 in and favors unidirectional rather than random migration.
vitro, macrophages remain the most abundant and best Nonetheless, the findings in their paper are consistent
established source in vivo. Macrophages isolated from with the possibility that ANCA contributes to the local
the inflammatory foci of patients with several diseases, release of IL-8 and accounts for the presence of neutro-
such as rheumatoid arthritis and idiopathic pulmonary phils in the lesions. However, I expect that similar obser-
fibrosis, constitutively express high levels of IL-8 mRNA vations will soon be made with chemokines specific for
and secrete large amounts of IL-8. IL-8 mRNA and monocytes and macrophages, which are the predominant
protein have been identified previously in the glomeruli inflammatory cell in crescentic GN.
of patients with GN and in increased amounts in their Perhaps the most intriguing unanswered question is
urine [12, 13]. In addition, macrophages isolated from what initiates the immune response that generates
the glomeruli of patients with rapidly progressive GN ANCA autoantibodies. Although I tend to favor some
have been reported to release IL-8 spontaneously [14]. pathogenic role for ANCA, I suggest that we should not
The ability of neutralizing anti-IL-8 antibodies to block lose sight of the possibility that they are the consequence
neutrophil infiltration in several models of acute in- and not a cause of the inflammatory response. For exam-
flammation, including GN [15], provides further evi- ple, it is conceivable that the process of glomerular or
dence of the functional role of IL-8 in vivo. vascular inflammation initiates the production of anti-
Cockwell and colleagues have also identified IL-8
MPO or anti-PR3 autoantibodies by exposing MPO or
mRNA in the inflamed glomeruli of patients with
PR3 on the surface of cytokine-primed and/or apoptoticANCA-associated GN at segmental, crescentic and pari-
leukocytes, thereby allowing the antigens to be presentedetal epithelial sites [8]. IL-8 protein localized at similar
to T cells, either directly or after phagocytosis by antigensites as well as to neutrophils within glomerular capillar-
presenting cells.ies. To determine if this expression of IL-8 might be
In the final analysis, given the information availablelinked to the presence of ANCA, they conducted a series
to date, my sense is that ANCA are, in some way, in-of in vitro studies and found that ANCA stimulates IL-8
volved in the pathogenesis of necrotizing vasculitis andproduction by neutrophils. They also showed that the
crescentic GN, but that they are fuel for the fire rathersupernatants of ANCA-stimulated neutrophils inhibit
than the spark that ignites the flame.neutrophil chemotaxis towards an IL-8 gradient. From
these results, the authors hypothesize that, despite heavy
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